IP Verse

Medical Use Of A Dpp-4 Inhibitor

Patent No. EP3110449 (titled "Medical Use Of A Dpp-4 Inhibitor") was filed by Boehringer Ingelheim on Feb 27, 2015. The application was issued on Jun 28, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GENERICS UKMar 28, 2024ELKINGTON AND FIFE
POLPHARMAMar 26, 2024HAMM & WITTKOPP
WUESTHOFF & WUESTHOFFMar 26, 2024SONNENHAUSER
TEVA PHARMACEUTICALSMar 21, 2024VON KAUFFMANN
SANDOZMar 13, 2024ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3110449

BOEHRINGER INGELHEIM
Application Number
EP15707338A
Filing Date
Feb 27, 2015
Status
Revoked
Jan 10, 2025
Publication Date
Jun 28, 2023
External Links
Slate, Register , Google Patents